1-8 of 8
James Mason
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long COVID-19 Infections and Organizing Pneumonia in a Series of Patients with Indolent Lymphoma Treated with Rituximab

David Savage, Marin Xavier, James Mason, Jacqueline Chang, Steven Escobar
Journal: Blood
Blood (2023) 142 (Supplement 1): 6133.
https://doi.org/10.1182/blood-2023-185505
Published: 2023
Journal Articles

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R. Wilson, Marina Konopleva, Arthur E. Frankel, Vikas Gupta, Ruben Mesa, Matthew Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James Mason, Maria Teresa Garcia-Romero, Norma Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland B. Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K. Rampal, Marcos de Lima, James Foran, Amir T. Fathi, Aric Cameron Hall, Meagan A. Jacoby, Jeffrey Lancet, Gabriel Mannis, Anthony S. Stein, Alice Mims, David Rizzieri, Rebecca Olin, Alexander Perl, Gary Schiller, Paul Shami, Richard M. Stone, Stephen Strickland, Matthew J. Wieduwilt, Naval Daver, Farhad Ravandi, Sumithira Vasu, Monica Guzman, Gail J. Roboz, Joseph Khoury, Muzaffar Qazilbash, Phyu P. Aung, Branko Cuglievan, Yazan Madanat, Mohamed A. Kharfan-Dabaja, Anna Pawlowska, Justin Taylor, Martin Tallman, Prajwal Dhakal, Andrew A. Lane
Journal: Blood
Blood (2023) 141 (6): 567–578.
https://doi.org/10.1182/blood.2022017865
Published: 2023
Journal Articles

Treatment with IMR-687, a Highly Selective PDE9 Inhibitor, Increases HbF and Reduces VOCs in Adults with Sickle Cell Disease in a Long-Term, Phase 2a, Open-Label Extension Study

Biree Andemariam, Timothy Mant, Perla Eleftheriou, Sanne Lugthart, Lanetta Bronté-Hall, Filipa Barroso, Gershwin Blyden, James Mason, Constance M Barysauskas, Joseph Yen, Karen Tang, Rahul Ballal, Kenneth Attie
Journal: Blood
Blood (2021) 138 (Supplement 1): 2046.
https://doi.org/10.1182/blood-2021-149536
Published: 2021
Journal Articles

Benefits and Safety of Long-Term Use of IMR-687 As Monotherapy or in Combination with a Stable Dose of Hydroxyurea (HU) in 2 Adult Sickle Cell Patients

Lanetta Bronte-Hall, MD MPH, MSPH, Biree Andemariam, MD, Blyden Gershwin, MD, Sanne Lugthart, MD PhD, Timothy Mant, MB, FFPM, FRCP, Jo Howard, MBBChir, MRCP, FRCPath, Henry Fok, MBBS, PhD, Perla Eleftheriou, FRCPath, MRCP, Robert Ward Hagar, MD, James Mason, DO, Rahul Ballal, PhD, Joelle Lufkin, MPH, Eleanor Lisbon, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-140540
Published: 2020
Journal Articles

Drug Sensitivity Across Acute Myeloid Leukemia Subtypes Using an in Vitro Assay

Levanto Schachter, DO, MSc, Irene M. Hutchins, MD, Jill Waalen, MD MPH, Carol Burian, CCRP, Darren Finlay, PhD, Kristiina Vuori, MD PhD, Giovanni Paternostro, MD PhD, Marin F. Xavier, MD, Carrie L. Costantini, MD, William E. Miller, MD, Jeffrey Andrey, MD, James Mason, MD
Journal: Blood
Blood (2016) 128 (22): 5208.
https://doi.org/10.1182/blood.V128.22.5208.5208
Published: 2016
Journal Articles

Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America

Christopher R. Flowers, MD, Michael Lill, M.D., Luciano J Costa, MD, PhD, Tsiporah B. Shore, William Vaughan, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, M.D., Mitchell E. Horwitz, MD, Joseph W. Fay, MD, Shin Mineishi, MD, Damiano Rondelli, MD, James Mason, MD, Vijay Reddy, MD, PhD, Ira Braunschweig, MD, Weiyun Ai, MD, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Cathy Zhao, PhD, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, Edmund K. Waller, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 768.
https://doi.org/10.1182/blood.V122.21.768.768
Published: 2013
Journal Articles

Phase I Study of a Neutralizing Monoclonal Anti-CTLA4 Antibody (MDX-010) in Patients with Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.

Asad Bashey, MD, PhD, Bridget Medina, Sue Corringham, RN, Mildred Pasek, Ewa Carrier, MD, Howard Streicher, MD, Israel Lowy, MD, PhD, James Mason, MD, Robert J. Soiffer, MD, Edward D. Ball, MD
Journal: Blood
Blood (2005) 106 (11): 2017.
https://doi.org/10.1182/blood.V106.11.2017.2017
Published: 2005
Journal Articles

Evidence of Donor Derived Malignancies Following Hematopoietic Stem Cell Transplantation.

Olga Sala-Torra, M.D., Michael R. Loken, Ph.D., Mary E.D. Flowers, M.D., Paula A. Ladne, M.S., James Mason, M.D, David Senitzer, Ph.D., Stephen J. Forman, M.D., Jerald Radich, M.D.
Journal: Blood
Blood (2004) 104 (11): 2247.
https://doi.org/10.1182/blood.V104.11.2247.2247
Published: 2004